Register entry
Nipro Pharma Corporation
- Registered sites
- 2
- Drug products
- 2
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingFinished drug manufacture
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| Nipro Pharma Corporation | IwasegunJapan | Analytical testing, Finished drug manufacture | 3010317053 |
| NIPRO PHARMA CORPORATION | ODATEJapan | Analytical testing, Finished drug manufacture | 3017952330 |
Catalogue
Marketed products
2Showing 2 of 2.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Ceftobiprole Medocaril Sodium for Injection | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | gefitinib tablets | TABLET | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.